iMedix Medical Content Engine 3.13.37

Vibramycin: Uses, Dosage & Safety Information

Vibramycin

Vibramycin

Vibramycin

Doxycycline
Vibramycin is the brand name for the antibiotic doxycycline hyclate. It is a tetracycline-class antibiotic prescribed to treat a variety of bacterial infections, including respiratory infections, acne, Lyme disease, and certain sexually transmitted diseases. It is also used for malaria prevention.
  • ActiveIngredient: Doxycycline
  • DosageForm: Capsule; tablet; oral suspension
  • Dosage: Historically supplied as hyclate capsules, monohydrate suspension and calcium syrup; current generic strengths counted as doxycycline
  • Indications: Rickettsial, respiratory, sexually transmitted, ophthalmic and other specific bacterial infections; malaria prophylaxis
  • Manufacturer: Brand Vibramycin no longer marketed; generic doxycycline widely available
  • Storage: Store as directed on the dispensed container; keep out of reach of children
  • Drug Status: Prescription
Brand no longer marketed
Vibramycin has left the market: Drugs@FDA returns no active application under that name, and no current prescribing information is published for it.
The molecule remains widely available as generic doxycycline. Everything on this page about dosing and safety comes from current doxycycline labelling, not from the discontinued brand’s own documentation.2

Vibramycin was Pfizer’s brand of doxycycline, a tetracycline-class antibacterial. It was the product through which doxycycline entered practice, and its family covered several different salts — hyclate capsules, monohydrate suspension, and a calcium syrup — each with its own application.

Those salts are why the same drug appears under several names. Doxycycline hyclate and doxycycline monohydrate are the same antibacterial in different chemical forms, and they are dosed by the amount of doxycycline they contain rather than by tablet weight.1

For current dosing, warnings and interactions, see doxycycline hyclate, which reflects labelling in force today.

Swallow with a full glass of water and stay upright afterwards. Doxycycline can irritate and ulcerate the oesophagus if a capsule lodges there.1

Separate it from antacids, iron, calcium and dairy. These bind tetracyclines in the gut and reduce absorption.

Avoid strong sun. Exaggerated sunburn reactions occur with tetracyclines, and the label directs stopping at the first sign of skin redness rather than covering up and continuing.

A prescription for Vibramycin will be filled with generic doxycycline. The name on the box differs from the name on the prescription, and that is expected.

Reported Side Effects
SystemEffectWhat the label says
Teeth and bonePermanent tooth discoloration, enamel hypoplasiaDuring tooth development — last half of pregnancy, infancy, and childhood to age 8
OesophagusIrritation and ulcerationTaken with adequate fluid to reduce the risk
SkinPhotosensitivityDiscontinue at the first evidence of skin erythema
Nervous systemIntracranial hypertensionReported; higher risk in women of childbearing age who are overweight or have a history of it
GastrointestinalNausea, vomiting, diarrhoeaAmong the commoner reactions
GastrointestinalClostridioides difficile-associated diarrhoeaReported with nearly all antibacterials

Source: 1

Emergency – stop and seek care
  • Headache with blurred or double vision, or any loss of vision
  • Pain on swallowing or pain behind the breastbone after a dose
  • Skin redness after sun exposure — stop the drug rather than shading up
  • Watery or bloody diarrhoea, during the course or weeks after

Doxycycline — the molecule Vibramycin delivered — is indicated for infections caused by susceptible bacteria across an unusually wide range.1

  • Rickettsial infections, including Rocky Mountain spotted fever and typhus
  • Respiratory tract infections caused by susceptible organisms
  • Sexually transmitted infections, including chlamydial infection and non-gonococcal urethritis
  • Ophthalmic, skin and other specific bacterial infections
  • Malaria prophylaxis and adjunctive therapy in acute intestinal amebiasis

What made the brand historically important was dosing rather than spectrum. The label still opens its dosing section in capitals with the same point: doxycycline is dosed differently from the other tetracyclines, and exceeding the recommended dose increases side effects rather than efficacy.1

A prescription written for Vibramycin today will be dispensed as generic doxycycline. The indication list does not change with the name.

Interactions Alcohol:

Consult your doctor
The label sets no alcohol restriction for doxycycline. Chronic alcohol use shortens its half-life, which matters more for a long course than for a short one.

Interactions Other Medications:

Use with caution
Methoxyflurane is contraindicated because of fatal renal toxicity reported with tetracyclines. Antacids, iron, calcium and dairy bind the drug in the gut and reduce absorption. Barbiturates, carbamazepine and phenytoin shorten its half-life, and oral anticoagulants may need dose reduction.

Special Groups Pregnancy:

Unsafe
Tetracyclines during the last half of pregnancy can cause permanent discoloration of the developing teeth. Use is weighed against that specific documented risk rather than a general caution.

Special Groups Breastfeeding:

Consult your doctor
Tetracyclines appear in breast milk, and the tooth-development concern extends to infancy. The decision belongs to the clinician treating the infection.

Special Groups Elderly:

Safe if prescribed
No separate geriatric regimen is set. Doxycycline is eliminated largely through the intestine rather than the kidney, which makes it easier to use where renal function has declined than most tetracyclines.

Special Groups Children:

Use with caution
Below eight years of age, tetracyclines may permanently discolour developing teeth. The label frames this as a benefit-risk judgement rather than a prohibition, which matters where the alternative is an untreated rickettsial infection. Above eight, dosing is by weight up to 45 kg.

Effects on Activities Driving:

Safe if prescribed
Doxycycline is not sedating. The exception is intracranial hypertension: headache with blurred or double vision means stopping and being assessed rather than driving on.

Effects on Activities Operating Machinery:

Safe if prescribed
The same applies. Visual symptoms are the reason to stop; ordinary side effects such as nausea rarely prevent machinery use.

Vibramycin is no longer marketed, and no current prescribing information is published under that name.2 The molecule is widely available as generic doxycycline hyclate and monohydrate.

The practical concern is name confusion rather than supply. Doxycycline reaches pharmacies under several salt names and several brand names, at strengths from 20 mg to 150 mg, and the dose is counted as doxycycline rather than as tablet weight. A prescription written from memory of the old brand needs checking against the strength actually dispensed.

Tooth development

Tetracyclines during tooth development — the last half of pregnancy, infancy, and childhood to age eight — may cause permanent yellow-grey-brown discoloration, and enamel hypoplasia has been reported. The risk is higher with long-term use but has followed repeated short courses. In children under eight the label frames this as a benefit-risk decision rather than an absolute bar, which matters where the alternative is an untreated rickettsial infection.

Oesophageal injury

Irritation and ulceration have occurred, particularly when a capsule is taken without enough fluid or immediately before lying down.

Photosensitivity

Exaggerated sunburn reactions occur. The instruction is to discontinue at the first evidence of skin erythema, not to continue with sun avoidance.

Intracranial hypertension

Reported with tetracyclines. Risk is higher in women of childbearing age who are overweight or have a history of the condition. Visual symptoms need prompt assessment, since vision loss can be permanent.

Source: 1

The regimens below come from current doxycycline labelling, since no Vibramycin-specific prescribing information remains in force.12

Approved Dosage
Indication / PopulationDose and FrequencyDuration / TimingClinical Notes
Adults, usual regimen200 mg on day one — as 100 mg every 12 hours or 50 mg every 6 hours — then 100 mg dailySet by infectionMaintenance may be split into two doses
Adults, more severe infection100 mg every 12 hoursSet by infectionParticularly for chronic urinary tract infection
Children over 8 years, 45 kg or less4.4 mg/kg on day one, then 2.2 mg/kg dailySet by infectionAbove 45 kg, adult dosing applies
All patientsTaken with adequate fluidEvery doseReduces the risk of oesophageal irritation and ulceration

Source: 1

Do not exceed the established dose
The label makes this point in capital letters: doxycycline dosing differs from other tetracyclines, and taking more increases side effects without increasing benefit.
Clinical detailstechnical detail

Doxycycline was the second-generation tetracycline that displaced the first: a semisynthetic modification gave it near-complete oral absorption, a long half-life allowing once or twice daily dosing, and clearance that does not depend on the kidney. Older tetracyclines needed four doses a day and accumulated in renal impairment.

Because it is eliminated largely through the intestine rather than by glomerular filtration, doxycycline is one of the few tetracyclines usable in patients with reduced kidney function — a property that survives the brand and explains why the molecule outlived Vibramycin by decades.1

Significant Interactions
Interacting substanceEffect and riskSeverityDocumentation
MethoxyfluraneFatal renal toxicity reported with tetracyclinesContraindicatedExcellent
Antacids, iron, calcium, magnesium, dairyChelation reduces absorption; doses separatedMajorExcellent
PenicillinsBacteriostatic drugs may interfere with the bactericidal action of penicillinsModerateGood
Oral anticoagulantsAnticoagulant dose may need reductionModerateGood
Barbiturates, carbamazepine, phenytoinShorten the half-life of doxycyclineModerateGood

Source: 1

No. Drugs@FDA returns no active application under the Vibramycin name, and no current prescribing information is published for it. A prescription written for Vibramycin will be dispensed as generic doxycycline, which is the same antibacterial.
They are two salts of the same antibacterial. Doses are counted as doxycycline rather than as tablet weight, so equivalent strengths deliver the same drug. Tolerability differs slightly for some people, and cost and availability differ more often than effect does.
Because a capsule that lodges in the oesophagus can cause irritation and ulceration. Taking each dose with adequate fluid and staying upright afterwards is the preventive measure the label specifies.
Above eight years, yes, dosed by weight up to 45 kg. Below eight, tetracyclines may permanently discolour developing teeth, and the label treats it as a benefit-risk decision rather than an absolute bar — which matters when the alternative is an untreated rickettsial infection such as Rocky Mountain spotted fever.
Yes, and the instruction is specific: discontinue at the first evidence of skin redness rather than continuing with sun avoidance. Exaggerated sunburn reactions are a recognised effect of the tetracycline class.
The same infections doxycycline treats today: rickettsial diseases including Rocky Mountain spotted fever, respiratory tract infections, chlamydial and other sexually transmitted infections, certain skin and eye infections, and malaria prophylaxis.

Evidence scope

What we know
  • Doxycycline dosing is defined for adults and for children over eight by weight, with the same regimen regardless of which salt is dispensed.
  • The paediatric tooth-development risk is bounded precisely: last half of pregnancy, infancy, and childhood to age eight.
  • Elimination is largely intestinal, so the drug is usable where renal function is reduced.
What remains uncertain
  • No prescribing information remains in force under the Vibramycin name, so brand-specific data cannot be verified against a current source.
  • How often intracranial hypertension occurs is not quantified in the labelling.
  • Whether tooth discoloration risk differs measurably between short and repeated short courses is described qualitatively rather than numerically.

Source: 12

What has been reported to the FDA

As of the FAERS data cut of 30 July 2026, the FDA Adverse Event Reporting System held 1,267 reports naming Vibramycin, of which 909 were classed as serious — 72% of the total. Doxycycline reporting overall runs to more than 17,000 reports under the generic names.3

Most Reported Terms
Coded termReports
Drug hypersensitivity136
Diarrhoea93
Dyspnoea87
Fatigue85
Nausea80
Pyrexia69
How to read this table

FAERS records what was reported, not what the medicine caused, and has no denominator – no count can become a rate.

Figures above are the counts held at the 30 July 2026 data cut, retrieved on 3 September 2026; they do not update between cuts.

Population note: this is a small dataset for a brand that left the market, and its shape reflects that history. Reports accumulated over decades of use and continue to be filed under the remembered brand name rather than the generic actually dispensed. None of the six leading terms is one of the effects the label warns about specifically — tooth discoloration, oesophageal ulceration, photosensitivity or intracranial hypertension. Absence from this list does not mean absence in practice; it reflects what gets reported.

Who was this medicine studied in?

Doxycycline dosing is established for adults and for children over eight years of age, by weight below 45 kg.1 Vibramycin was approved in the late 1960s, long before the Drug Trials Snapshot programme, and no snapshot exists.2

Who this is and is not appropriate for

Tetracyclines are avoided during tooth development unless the benefit outweighs the risk, and are contraindicated after hypersensitivity to any tetracycline. Methoxyflurane must not be given alongside.1

Anyone holding a prescription for Vibramycin will receive generic doxycycline. The clinical decision is about the molecule and the salt strength, not about the brand, which no longer exists as a supply route.

Where to go next

References — verified Sep 3, 2026

  1. Chartwell RX, LLC. Doxycycline capsules — prescribing information. DailyMed SPL set ID 02aa8731-d40f-43d8-8b63-a79a0503f8db, version 10, effective July 25, 2025. Cited as the applicable current labelling for the molecule, since none remains in force under the Vibramycin name. dailymed.nlm.nih.gov. Accessed September 3, 2026.
  2. US Food and Drug Administration. Drugs@FDA, queried for the Vibramycin brand. No active application and no current labelling are returned under that name. Accessed September 3, 2026.
  3. US Food and Drug Administration. FDA Adverse Event Reporting System, queried through openFDA for medicinalproduct VIBRAMYCIN. Data cut 2026-07-30 · Accessed 2026-09-03.

Three sources are listed because three are cited. Dosing and safety statements are drawn from current doxycycline labelling and attributed as such, because no Vibramycin-specific prescribing information remains in force.

This page is medical information, not medical advice. Vibramycin is a discontinued brand; the statements here about dosing and safety come from current doxycycline labelling and are attributed accordingly. Nothing here replaces assessment by the clinician treating you.

Advertising Disclosure: This page contains advertising. iMedix does not sell, dispense, or distribute medications, and is not responsible for transactions conducted on third-party websites. Advertising does not influence our medical content, which is independently written and reviewed by licensed healthcare professionals. See our Advertising Policy for details.